Skip to main content
Log in

Management of proteinuria secondary to penicillamine therapy in rheumatoid arthritis

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

To determine if a policy of continuing penicillamine therapy in successfully treated patients with rheumatoid arthritis in the presence of persistent proteinuria, was associated or not with resolution of this adverse effect, a computer record of patients receiving penicillamine for rheumatoid arthritis was searched for patients with persistent proteinuria and the case notes of these patients reviewed. Eleven patients with persistent proteinuria were identified, eight of whom did not have nephrotic syndrome and were continued on penicillamine with close monitoring. In 5 patients proteinuria resolved after 16–21 months; 3 developed peripheral oedema (2) or worsening of pre-existing hypertension and proteinuria (1). In one of these the proteinuria subsequently resolved and one died of unknown cause. Of the 3 initially nephrotic patients, two had resolved at the time of the study. Persistent proteinuria in penicillamine-treated patients with rheumatoid arthritis resolves with continued therapy in the absence of nephrotic syndrome but vigilence is required for the development of any complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bacon, P.A., et al. Penicillamine nephropathy in rheumatoid arthritis, Q J Med 1976, 45, 661–684.

    CAS  PubMed  Google Scholar 

  2. Crawhall, J.C. Proteinuria in D-penicillamine-treated rheumatoid arthritis. J Rheumatol 1981, 8 (supp 7), 161–163.

    Google Scholar 

  3. Jaffe, I.A. D-Penicillamine, Bull Rheum Dis 1978, 28, 948–952.

    CAS  Google Scholar 

  4. Hill, H.F.H. Treatment of rheumatoid arthritis with penicillamine. Semin Arthritis Rheum 1979, 6, 361–388.

    Article  Google Scholar 

  5. Davison, A.M., Day, A.T., Golding, J.R., Thomson, D. Effect of penicillamine on the kidney. Proc. Roy Soc Med 1977, 70 (Suppl 3), 109–112.

    PubMed  PubMed Central  Google Scholar 

  6. Kirby, J.D., Dieppe, P.A., Huskisson, E.C., Smith, B.D. Penicillamine and immune complex deposition. Ann Rheum Dis 1979, 38, 344–346.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ross, J.H. et al. Penicillamine nephropathy. Nephron 1980, 26, 184–186.

    Article  CAS  PubMed  Google Scholar 

  8. Day, A.T., et al. Penicillamine in rheumatoid disease; a long-term study. Br Med J 1974, i, 180–183.

    Article  Google Scholar 

  9. Jaffe, I.A., Penicillamine. In: Textbook of Rheumatology 3rd ed. Editor: Kelly, W.N., Harris, E.D., Ruddy, S., Sledge, C.B., Philadelphia, Saunders. 1989, 824–832.

    Google Scholar 

  10. Huskisson, E.C., Drugs which apparently affect the rheumatic disease process. In: Drug treatment of the rheumatic diseases 2nd ed. Editor: Hart, F.D. Balgowlah, ADIS Press. 1982, 61–82.

    Google Scholar 

  11. Hall, C.L., et al. Natural course of penicillamine nephropathy: a long-term study of 33 patients. Br Med J 1988, 296, 1083–1086.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

DeSilva, R.N., Eastmond, C.J. Management of proteinuria secondary to penicillamine therapy in rheumatoid arthritis. Clin Rheumatol 11, 216–219 (1992). https://doi.org/10.1007/BF02207960

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02207960

Key words

Navigation